Next wave of successful drug therapy strategies in HER2-positive breast cancer
Next wave of successful drug therapy strategies in HER2-positive breast cancer
Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer
How do we design trials that improve outcome?
Measurement variation influences gene expression profiles of breast cancer
The future of PI3K/AKT/mTOR inhibitors in breast cancer
Treatment of non-small cell lung cancer and adenocarcinoma
Treating adenocarcinoma with bevacizumab
Update on the METABRIC consortium 2000 Breast Cancer Study
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer
Implementation of individualised treatment and the WINTHER trial
Importance of personalised medicine and the WIN Consortium